Alan N. Schechter

Dr. Alan N. Schechter


Research Focus & Metrics

Academic Career Length

65Years (1962-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2003 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
KCKenyatta Cosby
Kenyatta Cosby
KPKristine S Partovi
Kristine S Partovi
JCJack H Crawford
Jack H Crawford
RPRakesh P. Patel
Rakesh P. Patel
CRChristopher D Reiter
Christopher D Reiter
MGMark T Gladwin
Mark T Gladwin

26 February 2004 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
MGMark T. Gladwin
Mark T. Gladwin
VSVandana Sachdev
Vandana Sachdev
MJMaria L. Jison
Maria L. Jison
YSYukitaka Shizukuda
Yukitaka Shizukuda
JPJonathan F. Plehn
Jonathan F. Plehn
FOFrederick P. Ognibene
Frederick P. Ognibene
The prevalence of pulmonary hypertension in adults with sickle cell disease, the mechanism of its development, and its prospective prognostic significance are unknown.

11 November 2002 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
CRChristopher D. Reiter
Christopher D. Reiter
XWXunde Wang
Xunde Wang
JTJose E. Tanus-Santos
Jose E. Tanus-Santos
NHNeil Hogg
Neil Hogg
RCRichard O. Cannon
Richard O. Cannon
MGMark T. Gladwin
Mark T. Gladwin

1 December 2009 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
JLJon Lundberg
Jon Lundberg
MGMark T Gladwin
Mark T Gladwin
AAAmrita AHLUWALIA
Amrita AHLUWALIA
NBNigel Benjamin
Nigel Benjamin
NBNathan S Bryan
Nathan S Bryan
EWEddie Weitzberg
Eddie Weitzberg

1 November 2005 in Nature Chemical Biology
Verified
Journal Article
Closed access
MGMark T Gladwin
Mark T Gladwin
ASAlan N. Schechter
Alan N. Schechter
DKDaniel B Kim-Shapiro
Daniel B Kim-Shapiro
RPRakesh P. Patel
Rakesh P. Patel
NHNeil Hogg
Neil Hogg
JLJon O Lundberg
Jon O Lundberg

1 April 1983 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RKR D Klausner
R D Klausner
JRJ Van Renswoude
J Van Renswoude
GAG Ashwell
G Ashwell
CKC Kempf
C Kempf
ASAlan N. Schechter
Alan N. Schechter
KBK R Bridges
K R Bridges
Human diferric transferrin binds to the surface of K562 cells, a human leukemic cell line. There are about 1.6 X 10(5) binding sites per cell surface, exhibiting a KD of about 10(-9) M. Upon warming cells to 37 degrees C there is a rapid increase in uptake to a steady state level of twice that obtained at 0 degree C. This is accounted for by internalization of the ligand as shown by the development of resistance to either acid wash or protease treatment of the ligand-cell association. After a minimum residency time of 4-5 min, undegraded transferrin is released from the cell. Internalization is rapid but is dependent upon cell surface occupancy; at occupancies of 20% or greater the rate coefficient is maximal at about 0.1-0.2 min-1. In the absence of externally added ligand only 50% of the internalized transferrin completes the cycle and is released to the medium with a rate coefficient of 0.05 min-1. The remaining transferrin can be released from the cell only by the addition of ligand, suggesting a tight coupling between cell surface binding, internalization, and release of internalized ligand. There is a loss of cell surface-binding capacity that accompanies transferrin internalization. At low (less than 50%) occupancy this loss is monotonic with the extent of internalization. Even at saturating levels of transferrin, the loss of surface receptors upon internalization never exceeds 60-70% of the initial binding capacity. This suggests that receptors enter the cell with ligand but are replaced so as to maintain a constant, albeit reduced, receptor number on the cell surface. In the absence of ligand, the cell surface receptor number returns at 37 degrees C. Neither sodium azide nor NH4Cl blocks internalization of ligand. However, they both prevent the release of transferrin from the cell thus halting the transferrin cycle. Excess ligand can overcome the block due to NH4Cl but not azide although the cycle is markedly slower. Iron is delivered to these cells by transferrin at 37 degrees C with a rate coefficient of 0.15 to 0.2 min-1. The iron is released from the transferrin and the majority is found in intracellular ferritin. There is a large internal receptor pool comprising 70 to 80% of the total cell receptors and this may be involved in maintaining the steady state iron uptake.